Literature DB >> 17854360

Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins.

P Gholam, M Hartmann, A Enk.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17854360     DOI： 10.1111/j.1365-2133.2007.08169.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 2.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Dermato-neuro syndrome in a case of scleromyxedema.

Authors:  Yusuf Savran; Sevgi Akarsu
Journal:  Eur J Rheumatol       Date:  2015-04-22

Review 4.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.

Authors:  Abtin Ansari; Zohre Erfani; Maryam Daneshpazhooh; Leila Mahmoudi; Zahra Saffarian; Kambiz Kamyab; Hamidreza Mahmoudi
Journal:  Case Rep Dermatol       Date:  2022-06-27

6.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

7.  Atypical Lichen Myxedematosus: A Case with Remarkable Response to Low Dose Melphalan.

Authors:  Mini Gomathy; Beena Sunny; Krishna Anitha; Sukumarakurup Sreekanth; Kunnaruvath Rajeevan; Soni C Das
Journal:  Indian Dermatol Online J       Date:  2017 May-Jun

8.  Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report.

Authors:  Federica Arginelli; Franco Rongioletti; Giampiero Girolomoni; Giovanni Pellacani; Davide Guardoli; Andrea Conti
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.